About Mark Hagler
Mark Hagler is a director at SLAM BioTherapeutics.
Mark Hagler first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Hagler in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Hagler works with at each company, as listed on that company's latest Form D.
SLAM BioTherapeutics, Inc. · Form D, Dec 29, 2025
RH
Richard Heinick
Executive Chairman and President
TS
Ted Schwartz
Director
SP
Steve Pazol
Director
DV
David Vennettilli
Director